TipRanks
Advertisement
Advertisement
NurExone Raises C$1.07 Million in Private Placement to Support Regenerative Therapy Push
PremiumCompany AnnouncementsNurExone Raises C$1.07 Million in Private Placement to Support Regenerative Therapy Push
1M ago
NurExone Preclinical Data Bolster Neuroprotective Case for ExoPTEN in Spinal Cord Injury
Premium
Company Announcements
NurExone Preclinical Data Bolster Neuroprotective Case for ExoPTEN in Spinal Cord Injury
2M ago
NurExone Strikes Exclusive U.S. GMP Exosome Manufacturing Pact with Made Scientific
Premium
Company Announcements
NurExone Strikes Exclusive U.S. GMP Exosome Manufacturing Pact with Made Scientific
2M ago
NurExone Bolsters European Push and Balance Sheet With Strategic Hire and C$880K Financing
PremiumCompany AnnouncementsNurExone Bolsters European Push and Balance Sheet With Strategic Hire and C$880K Financing
7M ago
NurExone to Spotlight Exosome Platform at Key 2026 Conferences as Executive Departs
Premium
Company Announcements
NurExone to Spotlight Exosome Platform at Key 2026 Conferences as Executive Departs
7M ago
NurExone Bolsters Exosome Manufacturing Consistency Ahead of Clinical Push
Premium
Company Announcements
NurExone Bolsters Exosome Manufacturing Consistency Ahead of Clinical Push
8M ago
NRX Earnings this Week: How Will it Perform?
PremiumPre-EarningsNRX Earnings this Week: How Will it Perform?
11M ago
NurExone Secures C$3.18 Million and Gains Global Recognition for Innovation
Premium
Company Announcements
NurExone Secures C$3.18 Million and Gains Global Recognition for Innovation
11M ago
NurExone Joins ARMI’s BioFab Lab to Boost U.S. Regenerative Manufacturing
Premium
Company Announcements
NurExone Joins ARMI’s BioFab Lab to Boost U.S. Regenerative Manufacturing
11M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―